|
KMID : 1094020190360030159
|
|
Journal of Veterinary Clinics
2019 Volume.36 No. 3 p.159 ~ p.165
|
|
|
Pharmacokinetics and Pharmacodynamics of Pimobendan-Pentoxifylline Liquid Mixture After Oral Administration in Dogs
|
|
Ro Woong-Bin
Song Doo-Won
Kim Ki-Hun
Jeong Sang-Hee
Kang Min-Hee
|
|
|
Abstract
|
|
|
|
Pimobendan is an inodilator used to treat canine heart failure, and pentoxifylline is reported to be beneficial for microcirculation and heart disease. The purpose of this study was to evaluate the pharmacokinetic and pharmacodynamic profiles of a novel pimobendan-pentoxifylline liquid mixture after oral administration to dogs. Eight healthy Beagle dogs were included in the study. The dogs were divided into the control group (orally administered water; n = 4) and experimental group (orally administered pimobendan-pentoxifylline liquid mixture [pimobendan 0.25 mg/ kg, pentoxifylline 15 mg/kg]; n = 4). Plasma samples were obtained and echocardiographic indices were measured for 24 hours after administration. The concentrations of pimobendan and pentoxifylline were quantified by using a liquid chromatography-mass spectrometer (LC-MS). The elimination half-life (T1/2) was 32.96 ± 9.80 mins for pimobendan and 29.49 ± 6.67 mins for pentoxifylline. The time to reach maximum concentration (Tmax) were 52.50 ± 31.22 mins for pimobendan and 41.25 ± 18.87 mins for pentoxifylline. The maximum blood concentration (Cmax) was 96.92 ± 75.64 ng/mL for pimobendan and 7074.07 ± 3261.1 ng/mL for pentoxifylline. Of the echocardiographic indices, fractional shortening (FS) and left ventricular internal diameter at end systole (LVIDs) were significantly altered at 1-3 hours after the administration of pimobendan-pentoxifylline liquid mixture. The pimobendan-pentoxifylline liquid mixture was well tolerated by the dogs, with no adverse effects observed during the study.
|
|
|
KEYWORD
|
|
|
pimobendan, pentoxifylline, liquid mixture, dogs
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|